JNJ vs PG
Johnson & Johnson vs The Procter & Gamble Company · Updated Sep 25, 2026
JNJ — 13 winsPG — 10 wins
Price Performance
JNJ +50.92%PG -4.11%
Performance
| JNJ | PG | |
|---|---|---|
| 1 Month | +0.40% | +0.83% |
| 3 Months | +6.45% | -1.89% |
| 6 Months | +13.31% | +2.65% |
| YTD | +30.99% | +2.02% |
| 1 Year | +53.42% | -4.49% |
| 3 Year | +66.44% | -5.73% |
| 5 Year | +80.04% | +12.83% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | +30.8% | +43.7% | -9.6% | -12.0% | +3.0% | +9.3% | +7.8% | +14.2% | -7.3% | +20.6% | +14.7% | -1.7% |
| PG | +3.1% | -13.7% | +12.7% | -3.3% | -7.0% | +18.7% | +12.8% | +36.8% | +1.4% | +9.1% | +7.3% | -12.2% |
Valuation
| JNJ | PG | |
|---|---|---|
| P/E Ratio | 31.34 | 21.37 |
| Forward P/E | 11.17 | 11.86 |
| PEG Ratio | 2.75 | 4.79 |
| P/S Ratio | 6.76 | 4.04 |
| P/B Ratio | 8.02 | 6.41 |
| EV/EBITDA | 20.46 | 15.57 |
Financials
| JNJ | PG | |
|---|---|---|
| EPS (TTM) | $8.65 | $6.84 |
| Gross Margin | +71.49% | +49.51% |
| Operating Margin | +26.58% | +21.55% |
| Net Margin | +21.76% | +0.09% |
| ROE | +25.92% | +23.23% |
| ROA | +10.47% | +9.90% |
| Debt/Equity | 0.22 | 0.68 |
Growth
| JNJ | PG | |
|---|---|---|
| Revenue Growth YoY | +9.91% | +7.38% |
| Revenue Growth QoQ | -2.04% | -4.38% |
| EPS Growth YoY | -52.86% | +5.84% |
| EPS Growth QoQ | +1.90% | -8.43% |
Technical
| JNJ | PG | |
|---|---|---|
| RSI (14) | 59.18 | 51.75 |
| % From 20-Day SMA | +0.53% | +0.14% |
| % From 50-Day SMA | +2.31% | +0.16% |
| % From 200-Day SMA | +12.80% | -0.77% |
| % From 52-Week High | -3.55% | -12.59% |
| % From 52-Week Low | +54.10% | +6.23% |
Analyst Ratings
JNJ
Buy(21 analysts)
Strong SellHoldStrong Buy
Price Target
$286.93
+5.50% upside
PG
Buy(16 analysts)
Strong SellHoldStrong Buy
Price Target
$157.78
+7.80% upside
Overview
| JNJ | PG | |
|---|---|---|
| Sector | Healthcare | Consumer Defensive |
| Industry | Drug Manufacturers - General | Household & Personal Products |
| Exchange | NYSE | NYSE |
| Market Cap | $651.20B | $350.66B |
| Shares Outstanding | 2.41B | 2.38B |
| Avg Volume (10D) | 6.52M | 7.54M |
| Dividend Yield | 1.95% | 2.91% |
Frequently Asked Questions
Is JNJ or PG a better buy right now?
Based on 23 comparable metrics, JNJ leads in 13 categories while PG leads in 10. JNJ has a consensus analyst rating with 21 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, JNJ or PG?
Over the past year, JNJ returned +53.42% compared to PG's -4.49%. In the short term (1 month), JNJ returned +0.40% vs PG's +0.83%.
Is JNJ or PG more expensive?
JNJ trades at a P/E of 31.34 compared to PG's 21.37. On a price-to-sales basis, JNJ trades at 6.76x vs PG's 4.04x. Forward P/E: JNJ at 11.17 vs PG at 11.86.
Which stock has higher growth, JNJ or PG?
JNJ's revenue grew +9.91% year-over-year compared to PG's +7.38%. EPS growth: JNJ at -52.86% vs PG at +5.84%.
Do JNJ and PG pay dividends?
JNJ pays a dividend with a yield of 1.95%. PG pays a dividend with a yield of 2.91%.
Which stock do analysts prefer, JNJ or PG?
JNJ has 21 analysts with a target price of $286.93 (+5.50% upside). PG has 16 analysts with a target of $157.78 (+7.80% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.